home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

31st International Conference on Cancer Research Therapy

 
  April 27, 2019  
     
 
Conference Series, Zurich,Switzerland
2019-09-09


Conference Highlights

  • Cancer Research    
  • Cancer Genetics   
  • Cancer Epigenetics
  • Cancer Science 
  • Cancer diagnostics
  • Cancer Therapies & prevention
  • Cancer Stem Cells
  • Biomarkers
  • Biopsy
  • Chemotherapy
  • Cancer screening  
  • Cancer Immunotherapy
  • Cancer Operomics
  • Carcinogenesis
  • Cancer nursing care
  • Cancer awareness
  • Experimental Therapeutics
  • Organ-specific cancer
  • Radiation therapy
  • Cancer alternative medicine
  • Cancer survivors
  • Malignancy aggravation
  • Personalized medicine
 
 
Organized by: Conference Series
Invited Speakers:

Cancer Research and therapy focus on innovative technologies. This gathering incorporates inspiring intelligent presentations and keynote speakers who will give a universal stage to discourse of present and future difficulties in Cancer research and therapy.

Asia Pacific Conferences organizes 1000+ Global Events comprehensive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe and Asia with support from 1000 more consistent social requests and conveys 900+ Open access journals contains in excess of 30000 celebrated identities, presumed researchers as article board individuals.

Cancer Research 2019 invites all interested participants to consolidate us for this honored event at the gorgeous destination Zurich,Switzerland.

Why to attend?

31st International Conference on Cancer Research and therapy is among the World's leading Scientific Conference. The two-day event on Cancer Research and therapy will host 60+ Scientific and technical sessions and sub-sessions on innovative researches in the field of Cancer Research and therapy across the globe. Cancer Research 2019 will constitute of 17 major sessions designed to offer comprehensive sessions that states current issues in the various field of Cancer research and therapy.

 

The attendees can find exclusive sessions and panel discussions on latest innovations in Advanced Cancer research and treatments by:

• Lectures from renowned speakers
• Keynote forums by Prominent Professors, Doctors
• Open Innovation Challenges
• Poster presentations by Young Researchers
• Global Networking sessions with 50+ Countries
• Novel techniques to benefit your research
• Best platform for Global business and Networking opportunities
• Meet the editors of referred journals, Society and Association members across the Globe
• Excellent platform to showcase the latest products and formulations in Oncology  field

 

Who Should Attend?
        Oncologists

        Radiologists

        Immunologists

        Pathologists

        Molecular Biologists

        Clinical Oncology Researchers

        Oncology Nurses

        Cancer Researchers

        Young Researchers

        Undergraduates

        Biomarker Associations and Societies

        Business Entrepreneurs

        Research Companies

 

 

Unique Features:

 

Our robust on-line publicity attracts 20000 users and 60000 views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences.The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows

 

Accepted Abstracts will be published in PubMed, MEDLINE, Pro Quest, SCOPUS, SOCOLAR, EBSCO, CAS, Hinari, Index Copernicus, Google Scholar, SCIRUS, DOAJ indexed journals

 

Venue & Hospitality : Zurich,Switzerland

 
Deadline for Abstracts: 25-08-2019
 
Registration:

https://medicaloncology.conferenceseries.com/registration.php

 

E-mail: globalpharmocovigilance2019@gmail.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.